Due to the site upgrade, your MY ACCOUNT logins will need to be updated. Please access Forgot Your Password to make this change. If you do not have an account, click here.

L-Carnitine decreases the risk of a blood clot in hemodialysis patients

Oct 13, 2010

     Kidney dialysis patients are prone to blood clots because their blood tends to coagulate. In this study thirty-six hemodialysis patients were randomly supplemented with L-Carnitine at 1000mg a day or with placebo for 12 weeks. In the L-Carnitine group plasma fibrinogen dropped 98mg/dl; fibrinogen is soluble in the blood but it converts to fibrin which forms a blood clot. C-Reactive protein, a proxy for inflammation, dropped by 41% on L-Carnitine. By decreasing fibrinogen and inflammation L-Carnitine is dropping the risk of having a stroke or heart attack or other blood clot related event. The study is published in the journal Renal Failure;32(9).